Oppenheimer & Co. Inc. Boosts Position in Danaher Corporation (DHR)
Oppenheimer & Co. Inc. boosted its position in shares of Danaher Corporation (NYSE:DHR) by 4.9% during the first quarter, Holdings Channel reports. The firm owned 34,021 shares of the conglomerate’s stock after buying an additional 1,603 shares during the period. Oppenheimer & Co. Inc.’s holdings in Danaher Corporation were worth $2,910,000 as of its most recent filing with the SEC.
Other hedge funds have also recently bought and sold shares of the company. Peddock Capital Advisors LLC boosted its stake in Danaher Corporation by 17.4% in the first quarter. Peddock Capital Advisors LLC now owns 1,224 shares of the conglomerate’s stock worth $105,000 after buying an additional 181 shares during the period. ClariVest Asset Management LLC purchased a new stake in Danaher Corporation during the first quarter worth approximately $157,000. Motco boosted its stake in Danaher Corporation by 26.7% in the first quarter. Motco now owns 1,848 shares of the conglomerate’s stock worth $158,000 after buying an additional 390 shares during the period. Baystate Wealth Management LLC boosted its stake in Danaher Corporation by 3.3% in the first quarter. Baystate Wealth Management LLC now owns 1,900 shares of the conglomerate’s stock worth $163,000 after buying an additional 60 shares during the period. Finally, Cedar Wealth Management LLC boosted its stake in Danaher Corporation by 5.3% in the first quarter. Cedar Wealth Management LLC now owns 2,286 shares of the conglomerate’s stock worth $196,000 after buying an additional 115 shares during the period. Institutional investors own 76.56% of the company’s stock.
Danaher Corporation (NYSE:DHR) traded up 0.67% during trading on Friday, hitting $79.82. The stock had a trading volume of 2,433,944 shares. Danaher Corporation has a 52-week low of $75.71 and a 52-week high of $88.01. The company has a market cap of $55.45 billion, a price-to-earnings ratio of 25.48 and a beta of 1.03. The firm’s 50-day moving average price is $82.89 and its 200-day moving average price is $84.21.
Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The firm had revenue of $4.51 billion during the quarter, compared to analyst estimates of $4.50 billion. During the same quarter in the previous year, the business earned $0.90 EPS. Danaher Corporation’s revenue for the quarter was up 6.3% compared to the same quarter last year. Analysts predict that Danaher Corporation will post $3.95 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: This report was first reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another domain, it was copied illegally and reposted in violation of U.S. & international copyright law. The correct version of this report can be accessed at https://www.dailypolitical.com/2017/08/12/oppenheimer-co-inc-boosts-position-in-danaher-corporation-dhr.html.
A number of research firms recently commented on DHR. Jefferies Group LLC reiterated a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub cut Danaher Corporation from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Wells Fargo & Company began coverage on Danaher Corporation in a research report on Thursday, July 13th. They set a “market perform” rating and a $90.00 price objective for the company. Zacks Investment Research cut Danaher Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 27th. Finally, BTIG Research reiterated a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a research report on Sunday, April 23rd. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $91.76.
In related news, insider William King sold 7,458 shares of Danaher Corporation stock in a transaction dated Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Angela S. Lalor sold 10,815 shares of Danaher Corporation stock in a transaction dated Tuesday, May 23rd. The shares were sold at an average price of $84.16, for a total value of $910,190.40. Following the completion of the transaction, the senior vice president now owns 39,020 shares of the company’s stock, valued at approximately $3,283,923.20. The disclosure for this sale can be found here. In the last 90 days, insiders sold 38,623 shares of company stock valued at $3,206,426. 12.20% of the stock is owned by company insiders.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.